Moxetumomab pasudotox-tdfk Intravenous and Pimavanserin Capsules
Determining the interaction of Moxetumomab pasudotox-tdfk Intravenous and Pimavanserin Capsules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
Generic Name: pimavanserin
Brand name: Nuplazid
Synonyms: Pimavanserin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Moxetumomab pasudotox-tdfk Intravenous-Pimavanserin Tablets
- Moxetumomab pasudotox-tdfk Intravenous-Pimavanserin Tartrate
- Moxetumomab pasudotox-tdfk Intravenous-Pimecrolimus
- Moxetumomab pasudotox-tdfk Intravenous-Pimecrolimus Cream
- Moxetumomab pasudotox-tdfk Intravenous-Pimecrolimus topical
- Moxetumomab pasudotox-tdfk Intravenous-Pimozide
- Pimavanserin Capsules-Moxifloxacin
- Pimavanserin Capsules-Moxifloxacin (Systemic)
- Pimavanserin Capsules-Moxifloxacin Hydrochloride
- Pimavanserin Capsules-Moxifloxacin Injection
- Pimavanserin Capsules-Moxifloxacin Intravenous
- Pimavanserin Capsules-Moxifloxacin Tablets